Oleg I. Barygin

Dr. Oleg I. Barygin

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Brain Research
Verified
Journal Article
Closed access
OBOleg I. Barygin
Oleg I. Barygin
ENElina I. Nagaeva
Elina I. Nagaeva
DTDenis B. Tikhonov
Denis B. Tikhonov
DBDarya A. Belinskaya
Darya A. Belinskaya
NVNina P. Vanchakova
Nina P. Vanchakova
NSNatalia N. Shestakova
Natalia N. Shestakova

12 April 2008 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
NDNatalia A. Dorofeeva
Natalia A. Dorofeeva
OBOleg I. Barygin
Oleg I. Barygin
ASAlexander Staruschenko
Alexander Staruschenko
KBKonstantin V. Bolshakov
Konstantin V. Bolshakov
LMLev G. Magazanik
Lev G. Magazanik
The inhibitory action of non‐steroid anti‐inflammatory drugs was investigated on acid‐sensing ionic channels (ASIC) in isolated hippocampal interneurons and on recombinant ASICs expressed in Chinese hamster ovary (CHO) cells. Diclofenac and ibuprofen inhibited proton‐induced currents in hippocampal interneurons (IC50 were 622 ± 34 μM and 3.42 ± 0.50 mM, respectively). This non‐competitive effect was fast and fully reversible for both drugs. Aspirin and salicylic acid at 500 μM were ineffective. Diclofenac and ibuprofen decreased the amplitude of proton‐evoked currents and slowed the rates of current decay with a good correlation between these effects. Simultaneous application of acid solution and diclofenac was required for its inhibitory effect. Unlike amiloride, the action of diclofenac was voltage‐independent and no competition between two drugs was found. Analysis of the action of diclofenac and ibuprofen on activation and desensitization of ASICs showed that diclofenac but not ibuprofen shifted the steady‐state desensitization curve to more alkaline pH values. The reason for this shift was slowing down the recovery from desensitization of ASICs. Thus, diclofenac may serve as a neuroprotective agent during pathological conditions associated with acidification.

24 June 2019 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
DBDaria A. Belinskaia
Daria A. Belinskaia
MBMariia A. Belinskaia
Mariia A. Belinskaia
OBOleg I. Barygin
Oleg I. Barygin
NVNina P. Vanchakova
Nina P. Vanchakova
NSNatalia Shestakova
Natalia Shestakova
Clinical observations have shown that patients with chronic neuropathic pain or itch exhibit symptoms of increased anxiety, depression and cognitive impairment. Such patients need corrective therapy with antidepressants, antipsychotics or anticonvulsants. It is known that some psychotropic drugs are also effective for the treatment of neuropathic pain and pruritus syndromes due to interaction with the secondary molecular targets. Our own clinical studies have identified antipruritic and/or analgesic efficacy of the following compounds: tianeptine (atypical tricyclic antidepressant), citalopram (selective serotonin reuptake inhibitor), mianserin (tetracyclic antidepressant), carbamazepine (anticonvulsant), trazodone (serotonin antagonist and reuptake inhibitor), and chlorprothixene (antipsychotic). Venlafaxine (serotonin-norepinephrine reuptake inhibitor) is known to have an analgesic effect too. The mechanism of such effect of these drugs is not fully understood. Herein we review and correlate the literature data on analgesic/antipruritic activity with pharmacological profile of these compounds.

1 March 2008 in Neuropharmacology
Verified
Journal Article
Closed access
TTT.B. Tikhonova
T.B. Tikhonova
OBOleg I. Barygin
Oleg I. Barygin
VGV.E. Gmiro
V.E. Gmiro
DTDenis B. Tikhonov
Denis B. Tikhonov
LML.G. Magazanik
L.G. Magazanik

1 February 2009 in Neuroscience Letters
Verified
Journal Article
Closed access
OBOleg I. Barygin
Oleg I. Barygin
VGValery E. Gmiro
Valery E. Gmiro
KKKira Kh. Kim
Kira Kh. Kim
LMLev G. Magazanik
Lev G. Magazanik
DTDenis B. Tikhonov
Denis B. Tikhonov